PMV Pharma issues warrants to buy 41,955,000 shares in $50.8 million offering
Reuters2026/09/01 03:04- PMV Pharmaceuticals priced a $50.8 million public offering featuring accompanying warrants to buy 41,955,000 common shares.
- Accompanying warrants carry an initial exercise price of $1.21 per share, immediately exercisable, expiring five years from issuance.
- Offering includes 22,055,000 common shares, pre-funded warrants for up to 19,900,000 shares, each sold with one accompanying warrant.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Global bond market sell-off intensifies! Australian bond yields hit a fifteen-year high as traders bet on Reserve Bank of Australia resuming rate hikes soon
Due to intensified global sovereign bond sell-offs and domestic inflation and consumption data continuously exceeding expectations, Australia’s benchmark government bond yield has risen to its highest level since 2011.
Japan’s MOF official says expects BoJ to steer policy aligned with economy, not influenced by US
2-Yr Benchmark Govt Yields - Germany vs Other Nations
10-Yr Benchmark Govt Yields - Germany vs Other Nations
Crypto prices
More
